TheEdgeResearch
Home / Stocks / JNJ

Johnson & Johnson (JNJ)

NYSE Healthcare Drug Manufacturers - General
$248.40 ▼ -2.15%
Market Cap
$597.95B
Sector
Healthcare
Industry
Drug Manufacturers - General
Beta
0.23
52-Wk Range
159.8-269.43
CEO
Joaquin Duato
Country
US
Currency
USD

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. i…

Open full interactive analysis & DCF →